Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
Clinical trial NCT04902781 · COMPLETED
Trial details
- NCT number
- NCT04902781
- Sponsor
- Applied Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-20
- Primary completion
- 2023-03-03
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.